InsiderSource
CDLX

Cardlytics, Inc.

SEC CIK 1666071
$5.41 −35.4% · 90 days
90-day buys
$129K
2 open-market
90-day sells
$241.2K
4 open-market
Net insider flow
−$112.2K
Net selling
Filings shown
65
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at CDLX have sold a net $112.2K of stock (2 open-market buys vs 4 sells).

Largest recent trade: Desieno Alexis sold $337.1K of CDLX, trimming their stake 50%.

Most active filer: Lynton Nicholas Hollmeyer, with 23 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for CDLX, newest first
View on SEC EDGAR ↗
Advertisement
CDLX
Cardlytics, Inc.
Buy Evans David Thomas · Chief Financial Officer · Open-market purchase · filed 3w ago ΔOwn +19%

Evans David Thomas, CDLX's CFO, spent $31.7K of their own money on 50,000 shares at $1, growing their stake 19%.

+$31.7K
50,000 sh @ $1
CDLX
Cardlytics, Inc.
Buy Evans David Thomas · Chief Financial Officer · Open-market purchase · filed 3w ago ΔOwn +127%

Evans David Thomas, CDLX's CFO, spent $97.4K of their own money on 150,000 shares at $1, growing their stake 127%.

+$97.4K
150,000 sh @ $1
CDLX
Cardlytics, Inc.
Sell Gupta Amit · Director, Chief Executive Officer · Open-market sale · filed Apr 6, 2026 ΔOwn −6.6%

Gupta Amit sold $82.9K of CDLX, trimming their stake 7%.

−$82.9K
69,833 sh @ $1
CDLX
Cardlytics, Inc.
Sell Gupta Amit · Director, Chief Executive Officer · Open-market sale · filed Apr 2, 2026 ΔOwn −4.9%

Gupta Amit sold $56.5K of CDLX, trimming their stake 5%.

−$56.5K
54,225 sh @ $1
CDLX
Cardlytics, Inc.
Option exercise Gupta Amit · Director, Chief Executive Officer · Option exercise · filed Apr 2, 2026 ΔOwn +74%
+$0
500,000 sh
CDLX
Cardlytics, Inc.
Sell Gupta Amit · Director, Chief Executive Officer · Open-market sale · filed Apr 2, 2026 ΔOwn −5.3%

Gupta Amit sold $61.9K of CDLX, trimming their stake 5%.

−$61.9K
62,549 sh @ $1
CDLX
Cardlytics, Inc.
Sell Lynton Nicholas Hollmeyer · Chief Legal & Privacy Officer · Open-market sale · filed Apr 2, 2026 ΔOwn −19%

Lynton Nicholas Hollmeyer sold $39.9K of CDLX, trimming their stake 19%.

−$39.9K
40,296 sh @ $1
CDLX
Cardlytics, Inc.
Sell Gupta Amit · Director, Chief Executive Officer · Open-market sale · filed Feb 18, 2026 ΔOwn −6.4%

Gupta Amit sold $41.8K of CDLX, trimming their stake 6%.

−$41.8K
45,159 sh @ $1
CDLX
Cardlytics, Inc.
Sell Gupta Amit · Director, Chief Executive Officer · Open-market sale · filed Feb 18, 2026 ΔOwn −6.9%

Gupta Amit sold $46.9K of CDLX, trimming their stake 7%.

−$46.9K
52,049 sh @ $1
CDLX
Cardlytics, Inc.
Option exercise Gupta Amit · Director, Chief Executive Officer · Option exercise · filed Feb 18, 2026 ΔOwn +20%
+$0
125,000 sh
CDLX
Cardlytics, Inc.
Sell Lynton Nicholas Hollmeyer · Chief Legal & Privacy Officer · Open-market sale · filed Jan 5, 2026 ΔOwn −4.8%

Lynton Nicholas Hollmeyer sold $7.3K of CDLX, trimming their stake 5%.

−$7.3K
6,253 sh @ $1
CDLX
Cardlytics, Inc.
Sell Gupta Amit · Director, Chief Executive Officer · Open-market sale · filed Jan 5, 2026 ΔOwn −1.1%

Gupta Amit sold $6.8K of CDLX, trimming their stake 1%.

−$6.8K
5,807 sh @ $1
CDLX
Cardlytics, Inc.
Sell DeSieno Alexis · Chief Financial Officer · Open-market sale · filed Jan 5, 2026 ΔOwn −4.1%

Desieno Alexis sold $10.1K of CDLX, trimming their stake 4%.

−$10.1K
8,607 sh @ $1
CDLX
Cardlytics, Inc.
Option exercise Gupta Amit · Director, Chief Executive Officer · Option exercise · filed Jan 5, 2026 ΔOwn +2.9%
+$0
14,349 sh
CDLX
Cardlytics, Inc.
Sell Lynton Nicholas Hollmeyer · Chief Legal & Privacy Officer · Open-market sale · filed Oct 2, 2025 ΔOwn −5.0%

Lynton Nicholas Hollmeyer sold $13.8K of CDLX, trimming their stake 5%.

−$13.8K
6,098 sh @ $2
CDLX
Cardlytics, Inc.
Sell Gupta Amit · Director, Chief Executive Officer · Open-market sale · filed Oct 2, 2025 ΔOwn −1.5%

Gupta Amit sold $17.7K of CDLX, trimming their stake 2%.

−$17.7K
7,799 sh @ $2
CDLX
Cardlytics, Inc.
Sell DeSieno Alexis · Chief Financial Officer · Open-market sale · filed Oct 2, 2025 ΔOwn −4.2%

Desieno Alexis sold $19.3K of CDLX, trimming their stake 4%.

−$19.3K
8,493 sh @ $2
CDLX
Cardlytics, Inc.
Option exercise Gupta Amit · Director, Chief Executive Officer · Option exercise · filed Oct 2, 2025 ΔOwn +2.9%
+$0
14,350 sh
Advertisement

About CDLX insider activity

This page tracks every recent Form 4 filed for Cardlytics, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

What are the latest CDLX insider transactions?

The most recent Form 4 filings for CDLX are listed at the top of this page, newest first, usually within minutes of SEC acceptance. Each row shows the insider, transaction code, share count, and dollar value.

How often is CDLX insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Cardlytics, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.